Urinary tract infections
In the USA, more than 8 million urinary tract infections (UTIs) occur each year in otherwise healthy young women [1, 2] . Approximately one in four women will experience a UTI within their lifetime and, of those, 30% will experience a recurrent infection within 3-6 months of the initial infection [3] . This incidence rate imposes an economic burden of approximately US$1.6 billion annually. The high costs of treatment and the high incidence rate emphasize UTI as a significant infectious disease process, which requires greater attention to better understand the underlying, complex pathogenic mechanisms [1, 2] . An individual's susceptibility to UTIs depends on behavioral, biological and genetic factors. The ultimate infectious outcome is determined by the balance between these factors and the bacteria's arsenal of defenses [4] . Escherichia coli is the predominant isolate recovered from afflicted women and is responsible for 80-90% of uncomplicated UTIs. Staphylococcus saprophyticus is the next most predominant organism responsible for UTIs and accounts for the remaining 10-15% of infections in young, healthy women. Additionally, Klebsiella, Proteus, Enterobacter and Enterococcus species can cause uncomplicated UTIs, but are often associated with complicated, nosocomial infections in immunocompromised, diabetic, elderly and urinary catheterized patients [5] . To date, uropathogenic E. coli (UPEC) is the best characterized UTI pathogen and serves as an appropriate model organism for targeted therapeutic design.
UPEC bacterial virulence factors
Bacterial genomes have evolved from less virulent ancestors to include a variety of genes or virulence factors necessary to overcome host defenses and subsequently establish disease states. Virulence gene acquisition is thought to have occurred by horizontal gene transfer in the case of pathogenicity islands (PAI), which contain gene clusters of a given functional category, or by selective environmental pressure. Virulence genes may reside on the chromosome or may be episomal and the degree of virulence of an organism is roughly proportional to the number of known virulence factors present in the genome [6, 7] . Virulence gene families identified thus far include proteinaceous adhesins, toxins, proteases, iron acquisition systems and the carbohydrate-based lipopolysaccharide and capsule [8] .
The toxins hemolysin (hlyA) and the secreted autotransporter protein (SAT) are associated with eukaryotic plasma membrane permeabilization and vacuolization, respectively. hlyA is a member of the repeats-in-toxin family and hlyA-induced pore formation in the plasma membrane leads to dose-dependent calcium oscillations and the triggering of an inflammatory response in rat renal proximal tubule cells [9, 10] . SAT, the secreted autotransporter toxin of UPEC, induces severe vacuolization and compromises gap junctions of bladder and kidney epithelium in vitro. In vivo, SAT produces significant renal histological changes in a mouse model of UTI, including dissolution of the glomerular membrane and vacuolation of proximal tubule cells [11] . UPEC may also encode for other toxins, such as cytotoxic For reprint orders, please contact: reprints@futuremedicine.com necrotizing factor type 1 (CNF-1), which has a more controversial role in UTI. CNF-1 constitutively activates rho GTPases and has been reported to inhibit phagocytosis by polymorphonuclear cells [12] , modulate polymorphonuclear cell function [12] and kill bladder epithelial cells in vitro [13] . Whereas Rippere-Lampe and colleagues demonstrate significantly attenuated bladder and urine colonization with cnf-deficient UPEC and a greater recovery of cnf-positive UPEC in co-challenge experiments [14] , Johnson and colleagues report no attenuation in host colonization or histological changes with cnf mutants [15] . Siderophore systems are probably exploited by UPEC to scavenge iron and enhance their survival in nutrient-limited environments, such as urine and the bladder [8, 16, 17] . Finally, most UPEC produce capsule, which is known to inhibit complement activation and phagocytosis by human polymorphonuclear cells. These actions protect UPEC from the innate immune system [18] . Bahrani-Mougeot and colleagues recently identified capsule as a pre-eminent virulence determinant in a signature-tagged mutagenesis screen for genes essential for survival in a mouse model of ascending UTI [19] . Nevertheless, of all the virulence factors, adhesins are the best studied owing to their crucial role in initiating bacterial-host contact. Interception of this intimate acquaintance is an ideal strategy to combat initial and recurrent host colonization events and to improve the lives of millions of people each year who suffer from UTIs.
Adhesin structure & function
Initiation of disease requires intimate contact of the pathogen with the host. As their name implies, adhesins perform this function and enable bacteria to adhere to abiotic and living tissues, a process that results in biofilm formation and initiation of host colonization events, respectively. Biofilms formed on abiotic surfaces are dynamic bacterial communities that exhibit antibiotic resistance, a growing concern in the treatment of bacterial infections [20] . In vivo, adhesins facilitate host colonization by mediating the first and crucial interaction with host tissue. In the case of UTIs, binding not only protects the bacterium from clearance by innate host defenses, such as the shear forces encountered during urination, but may also mediate invasion, whereby replication can occur in a protected, intracellular niche [21] . There are multiple families of adhesins, including type 4 pili, outer membrane proteins, curli, filamentous hemagglutinins and adhesive pili, also termed fimbriae, assembled by the chaperone-usher pathway. This review will focus on the latter group.
Adhesins assembled by the chaperone-usher pathway are nearly ubiquitous in Gram-negative organisms [22] , which often contain several adhesin gene clusters [23, 24] . Of importance in the urinary tract are the type 1, P, F1C, S and Afa/Dr families of adhesins. As a group, the adhesins share common genomic organization, assembly and, in the case of the fimbrial adhesins or pili, they share similar quaternary structural traits. Adhesin regulatory genes precede the major subunit gene, which is followed by the periplasmic chaperone, outer membrane usher and, finally, the operon terminates with the minor and adhesin subunit genes (Figure 1) . Organization of the pap operon differs by having the positions of the usher and chaperone inverted.
In addition to conserved organization of chaperone-usher adhesin gene clusters, conservation of subunit structure is apparent at the tertiary level despite primary sequence differences. The three dimensional structures of the adhesin-chaperone [25] , subunit-chaperone [26] and adhesin-receptor complexes [27] have been solved for type 1 and P pili, respectively, and demonstrate that subunits contain a single pilin domain with an incomplete immunoglobulin (Ig)-fold topology. The adhesins contain two domains: a pilin domain connected by a linker to the adhesin domain and an elongated 11-stranded β-barrel with a jelly roll-like topology in the case of FimH [25] . The adhesin domain confers receptor specificity and hence, tissue tropism to the pilus.
Crystallography and modeling studies have revealed that adhesin-receptor interactions are strikingly different among the fimbrial adhesins [28] . Thus, investigations of structure have provided insights into adhesin function, tissue tropism and the basis for pathogenesis. Formed by residues invariant among more than 200 UPEC strains, the type 1 pili adhesin, FimH, contains an acidic pocket at the distal tip that accommodates mono-mannose oligosaccharides [25, 29] , whereas PapG, the P pilus adhesin, binds
(GbO4)-containing receptors on the side using an elongated eight-stranded β-sandwich [27] . Structures of the F1C and S pili adhesins are not available but are expected to reveal unique binding sites for lactosylceramide-containing glycolipids and sialylated glycoproteins, respectively. Modeling of DraE, the Dr adhesin, onto Caf1, Sticky fibers and uropathogenesis: bacterial adhesins in the urinary tract -REVIEW the prototypic Yersinia pestis F1 antigen subunit, revealed two opposite binding sites. Daf-binding site residues are posited to cluster on a surface formed by DraE and an adjacent subunit [28] . The type IV collagen-binding site is located on the opposite face of the protein [30] .
Assembly of the fimbrial adhesins or pili by the highly conserved chaperone-usher pathway occurs via donor-strand exchange in which the Ig-fold of each mature subunit is completed by the N-terminal extension of the adjacent subunit (Figure 2 ) [31, 32] . Pilus biogenesis has been comprehensively reviewed elsewhere [33] . High resolution electron micrographs indicated that type 1, P, F1C and S pili are composite hair-like fibers that radiate peritrichously from the bacterial surface [28] . Pili consist of a right handed, rigid, hollow, helical rod comprised of thousands of repeating major subunits joined to a distal, flexible tip fibrillum containing adapter proteins and terminates with the cognate adhesin [34] . The type 1 pili tip fibrillum is short and stubby relative to the longer and flexible P, F1C and S tip fibrillum. Dr adhesins were initially classified as 'afimbrial' but may, in fact, be fine fibers that are sensitive to electron microscopy fixation techniques [35] .
Of importance in the urinary tract are the type 1, P, F1C, S and Afa/Dr families of adhesins. Each adhesin recognizes a specific receptor Tip fibrillum
in the urinary tract (Table 1) . Type 1 pili are essential in mediating cystitis and they recognize mono-and tri-mannose oligosaccharides present on the luminal surface of bladder epithelium [29] , Tamm-Horsfall protein [36] , type 1 and type IV collagens [37] , laminin [38] and fibronectin [39] . The minimum PapG receptor isotype is globotriasylceramide (GbO3). Receptor family members differ by addition of a single N-acetylgalactosamine (GalNAc) moiety to form globoside (GbO4), addition of two Gal-NAc moieties to create the Forssman antigen (GbO5), or by the addition of sialic acids to form more complex receptors [27, 40, 41] . Three PapG alleles exist (class I, II and III) and differentially bind to receptor family members. The class II allele is primarily associated with human pyelonephritis and the class III allele associated with human cystitis [42] [43] [44] . F1C and S pili are thought to play a role in ascending UTI. F1C pili recognize lactosylceramide-containing receptors [45, 46] whereas S pili recognize α-sialyl-2,3-β-galactoside (NeuNAcα[2-3]Gal)-containing receptors [47, 48] . Dr adhesins do not recognize carbohydrate-linked receptors but rather specifically bind the Dr(a+) blood group antigen present on the complement cascade regulatory factor, decay-accelerating factor, (DAF) or CD55 [49] . Dr adhesins are also known to bind type IV collagen [50] and α5β1 integrin [51] . Clinical isolate analysis suggests pregnant women to be most at risk for UTIs caused by UPEC that harbor Dr adhesins [52, 53] .
Adhesins & experimental models of UTI . F1C and P pili target glycosphingolipid receptors in the kidney to preferentially cause pyelonephritis. F1C pili may play a role in mediating mucosal inflammation as evidenced by renal epithelial cell interleukin-8 production in response to interaction with F1C positive bacteria [45] . P piliation provided UPEC with a fitness advantage in a murine model of ascending UTI by enhancing colonization and reducing the local secretory antibody immune response [55] . Similarly, pyelonephritis did not develop in primates challenged with PapG-negative pili [56] . Although S pili are predominantly correlated with neonatal meningitis and are harbored by sepsis clinical isolates, a formal role in UTI has yet to be demonstrated. However, in situ hybridization experiments demonstrated that S pili bind to human bladder and kidney epithelium [57] [58] [59] . Dr family adhesins recognize DAF, a complement regulatory protein found on most mammalian cells, which protects cells from autologous complement-mediated damage [60] . Although Dr family adhesins are associated with cystitis, these adhesins predominantly cause chronic pyelonephritis in mice [61] and human gestational pyelonephritis [53] , and are implicated in mortality in a pregnant rat model of intrauterine infection [62] . While all of these pili-tissue interactions appear important in UTI pathogenesis, the type 1 pili interaction with bladder epithelium is best characterized.
Intracellular replication in bladder epithelium
Historically, UTIs were considered luminal infections. However, intracellular niches in the form of UPEC 'pods' were discovered as a new reservoir [63, 64] . Uroplakin proteins (UPIa, Ib, II and III) line the bladder lumen in the form of hexameric, crystalline plaques, which form an impermeable barrier necessary for the prevention of solute and toxin retrograde absorption [65, 66] . Uropathogenic bacteria breach this barrier by P pili Globotriasylceramide (GbO3) Globoside (GbO4) Forssman antigen (GbO5)
GalB1-4GalX1-4GlcCer GalNaCX1-3GalB1-4GalX1-4GlcCer GalNacB1-3GalNaCX1-3GalB1-4GalX1-4GlcCer
Hemagglutionation with competitive inhibitor X-ray crystallography [87] [28]
F1C pili Lactosylceramide-containing glycolipids* GalX1-4GlcX1-Cer TLC overlay [46, 47] S pili B-sialyl-2,3-X-galactoside NeuNAcB(2-3)GalNeuramindase-sensitive hemagglutination [48, 49] Dr/Afa Decay-accelerating factor ---
*TLC overlay studies identified multiple F1C ligands; lactosylceramide was the common backbone of this family of ligands and the degree of F1C binding depended on fatty acid chain composition. TLC: Thin layer chromatography.
production of type 1 pili. FimH, the type 1 pilus adhesin, binds mannosylated uroplakins Ia and Ib, initiating invasion via a partial zippering mechanism [64] . Interestingly, UPIII is reported to contain the S pilus receptor and S pili have been demonstrated to bind murine and human bladder epithelium. Thus, the S pili-UPIII interaction may result in a protective binding event as well, although this hypothesis has not been tested formally in vivo. FimH-mediated invasion into the cytoplasmic milieu activates a complex developmental program (Figure 3) , whereby the bacteria form intracellular bacterial communities (IBC), a niche with biofilm-like properties protected from innate host defenses and antibiotic treatment [63, 64] . The cellular details of the IBC cascade have been visualized by high resolution time-lapse video microscopy using green fluorescent protein-positive UPECinfected, ex vivo bladder tissue [67] . The IBC maturation cascade is multifaceted and includes distinct events (Figure 3) . A loose collection of rod-shaped bacteria matures into a dense, globular shaped biomass containing more than 10 4 organisms within superficial umbrella cells. The bacteria within early IBCs undergo a reversible rod to cocci morphological change to allow greater bacterial packing within the IBC to form a three-dimensional structure reminiscent with biofilm-like properties [63, 68] . Realtime observation of IBC maturation suggests active aggregation mechanisms at work to maintain the dense, compact IBC ultrastructure. Although these aggregative factors are currently unknown, deepetch freeze fracture electron micrographs reveal fibers radiating from the bacterial surface, fibers similar to those presenting adhesins [63] .
Middle, or midstage, IBCs contain only coccoid bacteria with delayed doubling times of greater than 45 min. IBCs eventually reach maturity and the large intracellular biofilm-like mass takes over much of the facet cell cytoplasm. Once mature, IBC dispersal begins and dissemination of IBC progeny to naïve superficial umbrella cells initiates subsequent rounds of IBC formation, presumably by type 1 pili FimH-mediated invasion. Upon IBC dispersal, a subpopulation of UPEC has a filamentous morphology. Filamentous bacteria are more resistant to neutrophil attack, suggesting that filamentation may serve to protect against host attack and facilitate bacterial survival in the bladder [67] . Cycles of IBC formation continue at progressively slower rates until eventually, small clusters of intracellular bacteria are left, which form a silent, quiescent reservoir. The events that follow are not well understood, but are the focus of intense scientific inquiry: in response to unknown signals, bacteria within this reservoir re-activate and re-enter the IBC cascade to initiate recurrent infection [67] .
Overall, properly timed and coordinated gene expression undoubtedly functions to promote IBC maturation, to maintain bacterial and IBC viability, and to protect against innate host defenses. The identification of factors that confer the ability of UPEC to undergo the IBC cascade will highlight novel virulence factors in uropathogenesis for targeted therapeutic development. Moreover, IBC-like communities have also been described for Helicobactor pylori and Pseudomonas aeruginosa in a chronic atrophic gastritis model [69] and tracheal epithelial cell model [70] , respectively. It is an exciting and intriguing possibility that the IBC developmental cascade is universal and represents a paradigm in pathogen persistence and resistance against host defenses.
Newly discovered adhesin gene clusters All pathogens are not created equal in their ability to cause disease. In addition to the fim and pap operons, virulent uropathogenic strains contain other chaperone-usher pilus systems complete with putative adhesins. Most of these newly identified systems have yet to be characterized in urinary tract pathogenesis. The presence of multiple pilus systems likely confers niche-adaptive advantages that, for example, enable a bacterium to access the urethra via the genitourinary tract or to establish infection throughout the urinary tract, or to disseminate systemically in extreme infectious cases. As each site within these routes is unique, the combination of receptor specificity and tissue-specific receptor production will ultimately determine the site of action for a given pilus. Additionally, the newly discovered pilus systems may play roles in non-UTI disease processes.
Advent of the genomic era has allowed phylogenetic classification of uropathogens and has refined our understanding of disease phenotypes associated with a particular clinical isolate. Genome sequencing of a prototypic cystitis strain, UTI89, revealed ten different chaperone-usher (adhesin systems) or pilus systems [23] whose identity and locations are illustrated in Figure 4 . UTI89 contains the fim, pap, sfa, F17-like, auf, yad, yfc, yqi, yeh and fml operons, of which fim and pap have been best characterized for their roles in pathogenesis, as discussed previously.
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Although most commonly correlated with neonatal meningitis strains, the S-pili sfa gene cluster is present and expressed among 25-30% of UPEC clinical isolates [71, 72] . S pili have been shown to bind the extracellular matrix components fibronectin and laminin [73, 74] and sialoglycoproteins on brain microvascular endothelial cells [75] , an interaction that may explain migration across physiological barriers. S pili also bind to human bladder and kidney epithelium [57, 76] , suggesting relevance in UTI, although a direct correlation or role in disease has not been formally examined. Interestingly, pyelonephritic strain CFT073 contains the F1C (foc) operon in the same chromosomal location as the UTI89 sfa operon, further correlating S-pili and uropathogenesis, since F1C pili are suggested to be associated with UPEC isolates [71, 72, 77, 78] . The F17-like operon was annotated based upon its similarity to the F17 Binding and invasion of a single bacterium may lead to intracellular replication, ultimately forming an intracellular bacterial community with biofilm-like properties. Upon IBC maturation, uropathogenic Escherichia coli (UPEC) disseminate for additional rounds of type 1 pilimediated IBC formation in naïve superficial umbrella cells. Reservoir formation events are unclear at this time; however, reservoir UPEC are believed to reactivate and enter into the IBC cascade, resulting in recurrent urinary tract infection. Representative micrographs depict major events during the IBC cascade. Images modified from: * Mulvey and colleagues [64, 86] ; ‡ Anderson and colleagues [63] ; § Justice and colleagues [67] . IBC: Intracellular bacterial communities. pilus system found on PAI I in pyelonephritic isolate, 536 [79] . The prevalence of this gene cluster among UPEC isolates has yet to be determined and the F17 and F17-like pilus systems remain largely uncharacterized in UTI. However, a role in UTI pathogenesis is possible, given the conservation among the two UPEC isolates. Recently, a novel UPEC associated operon, auf, was identified in CFT073. Although this operon is highly prevalent in UPEC clinical isolates, deletion of this operon did not impact virulence in a murine model of UTI [80] . In UTI89, this operon is nonfunctional owing to a frame-shift mutation in aufG, the Auf fimbrial adhesin, and probably will not play a role in UTI89. To date, the other pilus operons yad, yfc, yqi, yeh and fml remain uncharacterized. A comprehensive analysis of each unknown chaperone-usher pilus in UTI pathogenesis is warranted and may provide insight into the mechanisms underlying disease initiation and progression. Characterization of their roles in UTI pathogenesis will also provide new targets for therapeutic intervention in the treatment and prevention of UTI.
Current & future therapies
The clinical paradigm for UTI management relies upon antibiotic treatment of infection. However, antibiotic resistance and intracellular reservoirs often defeat this standard treatment. The ongoing advances in our understanding of UTIs drive the development of several rational drug design approaches. One obvious strategy to inhibit UPEC colonization of the urinary tract is to inhibit pilus biogenesis. Another strategy, with particular promise to prevent recurrent UTI, is to target steps critical in the IBC developmental cascade. For example, one might inhibit the aggregation of UPEC into the dense biofilm-like collection of cells that renders protection from antibiotic therapy. Or, one might target the processes that lead to filamentation, which renders protection from host defenses. Alternatively, and perhaps most attractive, the ability to intercept the crucial adhesin-mediated binding of bacteria to host tissue may be more feasible than abolishing pilus biogenesis and is a target that can prevent initial and recurrent UTI.
To date, several lines of evidence support pilus biogenesis and adhesin inhibition as worthwhile approaches. Kihlberg and colleagues have 
UTI89 adhesin gene clusters
Sticky fibers and uropathogenesis: bacterial adhesins in the urinary tract -REVIEW described the development of P pili adhesin inhibitors that are 30-fold more potent than the natural ligand at blocking wild type PapG-GbO4 interactions [81] . Although promising, these drugs only target one pilus system and have yet to be tested in vivo in experimental models of UTI. FimC and PapD chaperone functions are essential for pilus biogenesis [82] and represent another target for inhibition. Compounds that interfere with chaperone activity are termed 'pilicides' and have proved efficient at significantly reducing both type 1 and P pilus biogenesis [83] . Similar to the PapG inhibitors, the pilicides are in need of in vivo analyses. Traditional approaches in combating infectious disease have also proved promising. Vaccination of mice and cynomolgus monkeys with FimCH demonstrates a greater than 99% reduction in mucosal colonization [84] and 75% reduction in both colonization and inflammation [85] , respectively. Ultimately, a combinatorial treatment approach should be considered that addresses both intra-and extracellular bacterial niches and the multitude of adhesins produced by the bacterium.
Conclusion
Uropathogenic bacteria navigate the complex landscape of the genitourinary tract and ascend the urethra to cause UTI via an arsenal of adhesins and virulence factors. The data reviewed here highlight the diversity of bacterial adhesins, the structural basis for tissue tropism, the consequences of type 1 pili-mediated invasion and the extensive number of pilus operons within UPEC genomes. Presumably, the additional pilus operons confer niche-adaptive adherence capabilities to the bacterium throughout the genito-urinary tract to aid in the establishment of UTI. The additional pilus systems may also play roles elsewhere in other physiological (e.g., gastrointestinal) and natural environments. Currently, type 1, P and Dr adhesins are best characterized for their direct roles in UTI. Nevertheless, the newly identified pilus gene clusters in UPEC genomes may provide additional adhesive resources for efficient host colonization.
Future perspective
The ever evolving use of niche-specific genes by bacteria illustrates the need for intelligent therapeutic design in treating acute and recurrent UTI. Given the crucial nature of tissue binding as the first step in the infectious process, the known adhesins and yet to be characterized adhesins provide rational targets for drug development. The substantial incidence rate and the aging population's risk of UTI demand our attention and necessitate the development of more efficacious UTI therapeutics.
Executive summary
• Urinary tract infections (UTIs) constitute one of the most common bacterial infections, with an incidence rate of more than 8 million infections per year.
• Uropathogenic Escherichia coli adhesins mediate adherence to and colonization of epithelial tissues throughout the urinary tract.
• Adhesin receptor specificity dictates tissue tropism and the subsequent urinary tract disease.
• Type1 pili bind mannosylated uroplakins in bladder epithelium and are essential cystitis virulence determinants.
• P pili bind α-D-galactopyranosol(1-4)-β-D-galactopyranoside (GbO4)-containing receptors in the upper urinary tract and initiate pyelonephritis.
• F1C pili recognize lactosylceramide receptors and are thought to play a role in ascending UTI.
• S pili recognize α-sialyl-2,3-β-galactoside (NeuNAcα(2-3)Gal)-containing receptors and are thought to play a role in ascending UTI.
• Dr family adhesins are associated with cystitis and are more commonly implicated in chronic and gestational pyelonephritis.
• Type 1 pili-mediated invasion leads to protected, intracellular replication in the form of intracellular biofilm communities.
• The current clinical paradigm must be dynamic and incorporate the newly discovered intracellular UPEC reservoir.
• This protected niche challenges clinicians and researchers in the treatment of UTI and the development of new therapeutics.
• Uropathogenic isolates contain multiple fimbrial systems for niche-adaptive adhesion during the establishment of UTI.
• Multiple adhesins provide additional targets for drug development to treat acute and recurrent UTIs using a combinatorial approach.
